In a recent study published in Science Translational Medicine, researchers profile antigen-specific helper clusters of differentiation 4-positive (CD4+) T-lymphocytes to determine anti-islet autoimmunity among mice and humans.
Dizal receives approval in China for NSCLC therapy
NSCLC is the most widespread cancer in China. Credit: Egor_Kulinich / Shutterstock.com. Dizal has received approval from China’s National Medical Products Administration (NMPA) for sunvozertinib